Modeling of Pharmacokinetics and Pharmacodynamics with Application to Cancer and Arthritis

Loading...
Thumbnail Image
Date
2012
Editors
Contact
Journal ISSN
Electronic ISSN
ISBN
Bibliographical data
Publisher
Series
URI (citable link)
DOI (citable link)
ArXiv-ID
International patent number
Link to the license
EU project number
Project
Open Access publication
Restricted until
Title in another language
Research Projects
Organizational Units
Journal Issue
Publication type
Dissertation
Publication status
Published in
Abstract
Mathematical modeling of pharmacokinetics / pharmacodynamics (PKPD) is an important and growing field in drug development. In this work we develop preclinical PKPD models based on fundamental biological and pharmacological principles.

Equipped with a PKPD model, different dosing schedules could be simulated and therefore, a valuable contribution to first in human dose selection could be achieved. We consider different mathematical model figures and discuss the properties and biological basis. Such tools serve as modules for a final PKPD model. We apply ordinary and delay differential equations and especially focus on modeling of delays and lifespans in populations. We show a fundamental relationship between transit compartments and lifespan models. Moreover, we investigate the weighted least squares estimator and derive statistical characteristics of model parameter.

We present a PKPD model to describe tumor growth and anticancer effects for mono- and combination therapy. Further, we construct a PKPD model for arthritis development and antibody effects.

Summarizing, we develop (semi)-mechanistic mathematical PKPD models based on pharmacological assumptions and apply our models to measured data from preclinical phase.
Summary in another language
Subject (DDC)
310 Statistics
Keywords
Conference
Review
undefined / . - undefined, undefined. - (undefined; undefined)
Cite This
ISO 690KOCH, Gilbert, 2012. Modeling of Pharmacokinetics and Pharmacodynamics with Application to Cancer and Arthritis [Dissertation]. Konstanz: University of Konstanz
BibTex
@phdthesis{Koch2012Model-19472,
  year={2012},
  title={Modeling of Pharmacokinetics and Pharmacodynamics with Application to Cancer and Arthritis},
  author={Koch, Gilbert},
  address={Konstanz},
  school={Universität Konstanz}
}
RDF
<rdf:RDF
    xmlns:dcterms="http://purl.org/dc/terms/"
    xmlns:dc="http://purl.org/dc/elements/1.1/"
    xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
    xmlns:bibo="http://purl.org/ontology/bibo/"
    xmlns:dspace="http://digital-repositories.org/ontologies/dspace/0.1.0#"
    xmlns:foaf="http://xmlns.com/foaf/0.1/"
    xmlns:void="http://rdfs.org/ns/void#"
    xmlns:xsd="http://www.w3.org/2001/XMLSchema#" > 
  <rdf:Description rdf:about="https://kops.uni-konstanz.de/server/rdf/resource/123456789/19472">
    <dcterms:isPartOf rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39"/>
    <dcterms:hasPart rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/19472/2/Diss_Koch.pdf"/>
    <dcterms:abstract xml:lang="eng">Mathematical modeling of pharmacokinetics / pharmacodynamics (PKPD) is an important and growing field in drug development. In this work we develop preclinical PKPD models based on fundamental biological and pharmacological principles.&lt;br /&gt;&lt;br /&gt;Equipped with a PKPD model, different dosing schedules could be simulated and therefore, a valuable contribution to first in human dose selection could be achieved. We consider different mathematical model figures and discuss the properties and biological basis. Such tools serve as modules for a final PKPD model. We apply ordinary and delay differential equations and especially focus on modeling of delays and lifespans in populations. We show a fundamental relationship between transit compartments and lifespan models. Moreover, we investigate the weighted least squares estimator and derive statistical characteristics of model parameter.&lt;br /&gt;&lt;br /&gt;We present a PKPD model to describe tumor growth and anticancer effects for mono- and combination therapy. Further, we construct a PKPD model for arthritis development and antibody effects.&lt;br /&gt;&lt;br /&gt;Summarizing, we develop (semi)-mechanistic mathematical PKPD models based on pharmacological assumptions and apply our models to measured data from preclinical phase.</dcterms:abstract>
    <dc:language>eng</dc:language>
    <dc:date rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-06-14T08:50:19Z</dc:date>
    <foaf:homepage rdf:resource="http://localhost:8080/"/>
    <dcterms:issued>2012</dcterms:issued>
    <dcterms:rights rdf:resource="https://rightsstatements.org/page/InC/1.0/"/>
    <dcterms:title>Modeling of Pharmacokinetics and Pharmacodynamics with Application to Cancer and Arthritis</dcterms:title>
    <dspace:isPartOfCollection rdf:resource="https://kops.uni-konstanz.de/server/rdf/resource/123456789/39"/>
    <dspace:hasBitstream rdf:resource="https://kops.uni-konstanz.de/bitstream/123456789/19472/2/Diss_Koch.pdf"/>
    <bibo:uri rdf:resource="http://kops.uni-konstanz.de/handle/123456789/19472"/>
    <dc:creator>Koch, Gilbert</dc:creator>
    <dc:rights>terms-of-use</dc:rights>
    <void:sparqlEndpoint rdf:resource="http://localhost/fuseki/dspace/sparql"/>
    <dc:contributor>Koch, Gilbert</dc:contributor>
    <dcterms:available rdf:datatype="http://www.w3.org/2001/XMLSchema#dateTime">2012-06-14T08:50:19Z</dcterms:available>
  </rdf:Description>
</rdf:RDF>
Internal note
xmlui.Submission.submit.DescribeStep.inputForms.label.kops_note_fromSubmitter
Contact
URL of original publication
Test date of URL
Examination date of dissertation
May 25, 2012
Method of financing
Comment on publication
Alliance license
Corresponding Authors der Uni Konstanz vorhanden
International Co-Authors
Bibliography of Konstanz
Yes
Refereed